2008 Reference Document is available
Innate Pharma announces its turnover for the first quarter of 2009 and updates on its cash situation
Innate Pharma appoints Marcel Rozencweig, MD, as Senior Vice President, clinical and regulatory strategy
Innate Pharma updates on its next meetings with analysts and investors
Prestigious award for Alessandro Moretta
P.Pouletty and B.Malissen bring their expertise to innate immunity company
New research laboratories in Marseilles
French innovation agency, ANVAR, grants loan to support product development
Innate Pharma welcomes Inserm as new shareholder
Prestigious award for David Raulet
